GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $61,590,000 | +23.3% | 1,517 | +31.0% | 0.01% | +25.0% |
| Q2 2017 | $49,933,000 | -36.0% | 1,158 | -37.4% | 0.00% | -42.9% |
| Q1 2017 | $78,038,000 | +189.1% | 1,851 | +164.1% | 0.01% | +133.3% |
| Q4 2016 | $26,996,000 | -78.1% | 701 | -75.3% | 0.00% | -81.2% |
| Q2 2016 | $123,086,000 | +1255.1% | 2,840 | +1167.9% | 0.02% | +1500.0% |
| Q1 2016 | $9,083,000 | -22.1% | 224 | -22.5% | 0.00% | -50.0% |
| Q4 2015 | $11,661,000 | -86.1% | 289 | -84.1% | 0.00% | -88.9% |
| Q3 2015 | $83,804,000 | +90.9% | 1,823 | +122.0% | 0.02% | +80.0% |
| Q2 2015 | $43,907,000 | +380.5% | 821 | +314.6% | 0.01% | +400.0% |
| Q1 2015 | $9,138,000 | -13.8% | 198 | -20.2% | 0.00% | -33.3% |
| Q4 2014 | $10,600,000 | -87.4% | 248 | -86.4% | 0.00% | -82.4% |
| Q3 2014 | $83,803,000 | +356.8% | 1,823 | +431.5% | 0.02% | +142.9% |
| Q2 2014 | $18,344,000 | +0.1% | 343 | 0.0% | 0.01% | -36.4% |
| Q1 2014 | $18,326,000 | – | 343 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |